This chapter delves into the ethical considerations surrounding gene editing, discussing the distinctions between somatic and germline gene editing and highlighting the advancements in technology. It raises concerns about genetic inequality, the loss of diversity, and the need for regulation to prevent misuse. The conversation underscores the importance of societal engagement in shaping the ethical landscape of gene editing.
Ulta Beauty’s CEO steps down. Docusign and JD.com decline on earnings. Bumble bounces higher. Poshmark misses the mark. Roblox has a big debut. And Dick’s Sporting Goods and Funko deliver on earnings. Motley Fool analysts Emily Flippen and Jason Moser discuss those stories, take stock of the sports betting market, and share two stocks on their radar: DexCom and Coupang. Plus, bestselling author Walter Isaacson talks about his new book, The Code Breaker: Jennifer Doudna, Gene Editing, and the Future of the Human Race.
Learn more about your ad choices. Visit megaphone.fm/adchoices